Data and Information
The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.
HIMSS25
Gunnar Trommer of BCG X and Erik Adams of BCG give highlights of their upcoming HIMSS25 panel on the capital needed to develop and commercialize AI-powered medical devices and on completing regulatory milestones like 510(k) clearance.
Van Steel, shareholder in LBMC's cybersecurity division, discusses his role at HIMSS Tennessee chapter - and why private healthcare data, including financial information, medications and other personal information, sells for a premium.
HIMSS25
Claroty's Ty Greenhalgh and St. Luke's University Health's Mike Powers say that, due to lack of patient focus by some IT personnel, initial hurdles were sharing knowledge back and forth and making sure that everyone was on the same page.
The Series C raise comes less than a year after the company secured $50 million in a Series B funding round.
Ian Shakil, chief strategy officer at Commure, explores the role of AI in clinical documentation and note-taking, emphasizing the importance of keeping humans in the loop and expanding the technology's impact across healthcare.
Patients are interested in AI to try and garner more information about their care or their child's care. Tools like ChatGPT are being utilized more by patients, says Dr. Samuel Browd of UW and Seattle Children's and the CMO at Proprio.
PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
AI models used to enhance cybersecurity include supervised, unsupervised machine learning and genAI that can take complex data and distill it down to something human-readable, says Etay Maor, Cato Networks' chief security strategist.